Brian Buckham, senior vice president and general counsel, will succeed Keen, effective March 1, 2022. Keen will continue to serve as a senior vice president after March 1 until he retires.
Meanwhile, Pat Harrington will assume the role of vice president, general counsel and will also retain his role as corporate secretary, according to a statement.
Price: 106.38, Change: +0.06, Percent Change: +0.06
|Pfizer, Roivant Sciences Launch New Joint Biotechnol...|
|Top Premarket Decliners|
|Cowen Adjusts Nike's Price Target to $127 From $133,...|
|Morgan Stanley Adjusts Nike's Price Target to $149 F...|
|Soligenix Says FDA Approves Investigational New Drug...|